Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Molecular Medicine Reports|June 8, 2019
IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancerLiguo Liu, Huizhuo Sun, Shan Wu, et al.Oncology Reports|December 27, 2021
Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy targetYu Feng, Liguo Liu, Jing Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
HBV-Specific TCR-T Cell Therapy Combining mRNA Electroporation and Lentiviral Transduction: Treatment Regime for Recurrent HBV-Related HCC Post-Liver TransplantationQiang Zhao, Jinbo Huang, Weixin Luo, et al.Immunity|April 8, 2018
Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8+ T CellsJing Li, Younghee Lee, Yanjian Li, et al.Cell Death & Disease|August 4, 2024
Role of N6-methyladenosine in tumor neovascularizationLu Zhao, Qinshan Li, Tongliang Zhou, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 6, 2024
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safetyJiahao Li, Meiting Qin, Yunhua Tang, et al.Cancer Medicine|March 31, 2023
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implicationsZhiming Zhao, Xiaomo Li, Fei Wang, et al.BMJ Open|November 27, 2019
Protocol for the CREST Choles (Chinese REgistry Study on Treatment of Cholecysto-Choledocholithiasis) study: an ambispective, multicenter, observational, open-cohort studyJie-Gao Zhu, Shanshan Wu, Qiushi Feng, et al.Journal of Hepatocellular Carcinoma|October 27, 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort StudyXiaokun Chen, Jiali Xing, Baoluhe Zhang, et al.Journal of Hepatocellular Carcinoma|March 24, 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching StudyXiaokun Chen, Xiangan Wu, Wei Peng, et al.Pageof 9